Aveanna Healthcare Holdings Inc. $AVAH Shares Sold by Squarepoint Ops LLC

Squarepoint Ops LLC cut its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 27.6% during the second quarter, Holdings Channel reports. The institutional investor owned 633,900 shares of the company’s stock after selling 241,281 shares during the quarter. Squarepoint Ops LLC’s holdings in Aveanna Healthcare were worth $5,433,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of AVAH. AQR Capital Management LLC raised its position in Aveanna Healthcare by 21.2% in the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock worth $142,000 after acquiring an additional 4,602 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Aveanna Healthcare by 8.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock worth $1,842,000 after purchasing an additional 25,974 shares in the last quarter. Jane Street Group LLC boosted its position in shares of Aveanna Healthcare by 522.0% during the 1st quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock worth $407,000 after purchasing an additional 63,010 shares in the last quarter. Creative Planning grew its stake in shares of Aveanna Healthcare by 15.1% during the 2nd quarter. Creative Planning now owns 47,025 shares of the company’s stock worth $246,000 after purchasing an additional 6,171 shares during the period. Finally, JPMorgan Chase & Co. grew its stake in shares of Aveanna Healthcare by 65.0% during the 2nd quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company’s stock worth $828,000 after purchasing an additional 62,348 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on AVAH shares. Wall Street Zen cut shares of Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 15th. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. UBS Group increased their target price on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a report on Friday, August 14th. BMO Capital Markets lifted their price target on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Finally, Royal Bank Of Canada boosted their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a research note on Monday, August 24th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $13.50.

Insider Transactions at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 2,250,000 shares of the firm’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $11.50, for a total transaction of $25,875,000.00. Following the completion of the transaction, the insider owned 12,315,892 shares of the company’s stock, valued at approximately $141,632,758. This trade represents a 15.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of the business’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the transaction, the insider directly owned 12,315,892 shares of the company’s stock, valued at approximately $141,632,758. This trade represents a 15.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 59,904,505 shares of company stock worth $649,301,514 in the last quarter. Insiders own 5.30% of the company’s stock.

Aveanna Healthcare Stock Performance

NASDAQ:AVAH opened at $14.08 on Friday. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47. The company has a market capitalization of $3.07 billion, a P/E ratio of 11.45, a price-to-earnings-growth ratio of 0.87 and a beta of 1.97. The firm has a 50-day moving average price of $11.19 and a two-hundred day moving average price of $8.53. Aveanna Healthcare Holdings Inc. has a twelve month low of $5.93 and a twelve month high of $14.54.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.05. The company had revenue of $670.48 million for the quarter, compared to the consensus estimate of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. As a group, research analysts expect that Aveanna Healthcare Holdings Inc. will post 0.75 earnings per share for the current fiscal year.

About Aveanna Healthcare

Aveanna Healthcare Corporation is a provider of home-based healthcare services for children, adults and families in the United States. The company’s services are designed to help patients receive medical and supportive care in their homes and communities, including individuals with complex, chronic or medically fragile conditions.

Aveanna’s principal services include private-duty nursing, home health, hospice and personal care. It also provides pediatric therapy and related clinical services, including physical, occupational and speech therapy.